名臣健康（002919）7月31日主力资金净流出1475.58万元

Financial Performance - As of July 31, 2025, Mingchen Health (002919) reported a closing price of 16.11 yuan, down 3.01% with a turnover rate of 2.02% and a trading volume of 53,300 lots, amounting to 86.79 million yuan [1] - For Q1 2025, the company reported total operating revenue of 361 million yuan, a year-on-year decrease of 0.10%, and a net profit attributable to shareholders of 12.71 million yuan, down 71.62% year-on-year [1] - The company's current ratio is 2.459, quick ratio is 2.166, and debt-to-asset ratio is 25.34% [1] Capital Flow - On the reporting day, the main capital outflow was 14.76 million yuan, accounting for 17.0% of the total transaction amount [1] - Large orders saw a net outflow of 13.21 million yuan, representing 15.22% of the transaction amount, while small orders had a net inflow of 9.34 million yuan, accounting for 10.76% [1] Company Overview - Mingchen Health Products Co., Ltd. was established in 1994 and is located in Shantou City, primarily engaged in the manufacturing of chemical raw materials and chemical products [2] - The company has a registered capital of 2.67 billion yuan and a paid-in capital of 610.64 million yuan [1] - The legal representative of the company is Chen Jianming [1] Investment and Intellectual Property - Mingchen Health has invested in 5 external enterprises and participated in 10 bidding projects [2] - The company holds 2 trademark registrations and 91 patents, along with 33 administrative licenses [2]